ResearchMoz

Liver Cancer Therapeutics Market to 2018 - Nexavar, the Only Approved Targeted Therapy for Advanced Disease, Continues to Dominate as Other Late Stage Trials Fail

GBI Research
Published Date » 2012-12-31
No. Of Pages » 72
     
  Liver Cancer Therapeutics Market to 2018 - Nexavar, the Only Approved Targeted Therapy for Advanced Disease, Continues to Dominate as Other Late Stage Trials Fail  
     
  Summary  
   
 Leading business intelligence provider, GBI Research, has released its latest research report, entitled: “Liver Cancer Therapeutics Market to 2018 - Nexavar, the Only Approved Targeted Therapy for Advanced Disease, Continues to Dominate as Other Late Stage Trials Fail”. The report provides insights into the liver cancer therapeutics market in the US, the top five European countries (the UK, Germany, France, Italy and Spain) and Japan, with market forecasts until 2018. It provides in-depth analysis of the major marketed products, as well as insights into the liver cancer...
Table of Contents

1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 8

2 Liver Cancer Therapeutics Market to 2018 - Introduction 9

3 Liver Cancer Therapeutics Market to 2018 - Overview 10
3.1 Introduction 10
3.1.1 Benign Tumor 10
3.1.2 Primary Liver Cancer 10
3.1.3 Secondary Liver Cancer 10
3.2 Symptoms 11
3.3 Diagnosis 11
3.3.1 Laboratory Tests 11
3.3.2 Imaging Tests 11
3.3.3 Others 12
3.4 Treatment Options 12
3.4.1 Surgery 13
3.4.2 Non-surgical 13
3.4.3 General Treatment Algorithm 15
3.4.4 Treatment by Stage 16
3.4.5 New Technologies in Treatment 18

4 Liver Cancer Therapeutics Market to 2018 - Market Characterization and Forecasts 19
4.1 Revenue 19
4.2 Annual Cost of Therapy 22
4.3 Marketed Products 23
4.3.1 Nexavar 23
4.3.2 Miripla 25
4.4 Treatment Usage Pattern 27
4.4.1 Prevalence Population 28
4.4.2 Diagnosed Population 28
4.4.3 Prescription Population 28
4.5 Drivers and Barriers of Liver Cancer Therapeutics Market 28
4.5.1 Drivers 28
4.5.2 Barriers 29

5 Liver Cancer Therapeutics Market to 2018 - Geographical Landscape 30
5.1 US 30
5.1.1 Introduction 30
5.1.2 Revenue 30
5.1.3 Cost of Therapy 32
5.1.4 Treatment Usage Pattern 33
5.2 Top Five European Countries 34
5.2.1 Introduction 34
5.2.2 Revenue 34
5.2.3 Cost of Therapy 36
5.2.4 Treatment Usage Pattern 37
5.3 Japan 38
5.3.1 Introduction 38
5.3.2 Revenue 38
5.3.3 Cost of Therapy 39
5.3.4 Treatment Usage Pattern 40

6 Liver Cancer Therapeutics Market to 2018 - Pipeline Analysis 41
6.1 Introduction 41
6.2 R&D Product Pipeline by Stage of Development 43
6.2.1 Phase III 43
6.2.2 Phase II/III 44
6.2.3 Phase II 44
6.2.4 Phase I/II 45
6.2.5 Phase I 46
6.2.6 Pre-Clinical 47
6.2.7 Discovery 47
6.3 Profiles of Promising Molecules 48
6.3.1 PrevOnco 48
6.3.2 Ramucirumab 48
6.3.3 ThermoDox 49
6.3.4 Afinitor 50

7 Liver Cancer Therapeutics Market to 2018 - Competitive Landscape 51
7.1 Bayer 51
7.2 Dainippon Sumitomo Pharma 52

8 Liver Cancer Therapeutics Market to 2018 - Strategic Consolidations 53
8.1 Introduction 53
8.2 Deals by Geography 54
8.3 Deals by Year 55
8.4 Mergers and Acquisition Deals 56
8.4.1 Overview 56
8.4.2 Profiles of Major M&A Deals 57
8.5 Licensing Agreements 58
8.5.1 Overview 58
8.5.2 Profiles of Major Licensing Agreements 60
8.6 Co-Development Agreements 62
8.6.1 Overview 62
8.6.2 Profiles of Major Co-Development Agreements 63

9 Liver Cancer Therapeutics Market to 2018 - Appendix 64
9.1 Market Definitions 64
9.2 Abbreviations 64
9.3 Bibliography 66
9.4 Research Methodology 67
9.4.1 Coverage 67
9.4.2 Secondary Research 68
9.4.3 Primary Research 68
9.5 Therapeutic Landscape 69
9.5.2 Market Size by Geography 70
9.6 Geographical Landscape 71
9.7 Pipeline Analysis 71
9.8 Competitive Landscape 72
9.8.1 Expert Panel Validation 72
9.9 Contact Us 72
9.10 Disclaimer 72

List of Tables


Table 1: Liver Cancer Therapeutics Market, Top Seven Markets, Revenue ($m), 2004-2011 19
Table 2: Liver Cancer Therapeutics Market, Top Seven Markets, Revenue Forecasts ($m), 2011-2018 19
Table 3: Liver Cancer Therapeutics Market, Top Seven Markets, Revenue by Geography ($m), 2004-2011 20
Table 4: Liver Cancer Therapeutics Market, Top Seven Markets, Revenue Forecasts by Geography ($m), 2011-2018 21
Table 5: Liver Cancer Therapeutics Market, Top Seven Markets, Annual Cost of Therapy ($), 2004-2011 22
Table 6: Liver Cancer Therapeutics Market, Top Seven Markets, Annual Cost of Therapy ($), 2011-2018 22
Table 7: Liver Cancer Therapeutics Market to 2018, Nexavar, Clinical Trial Results 23
Table 8: Liver Cancer Therapeutics Market, Nexavar, Adverse Reactions Reported in Clinical Trial 24
Table 9: Liver Cancer Therapeutics Market, Nexavar, Approval History 25
Table 10: Liver Cancer Therapeutics Market, Top Seven Markets, Treatment Usage Pattern (‘000), 2004-2011 27
Table 11: Liver Cancer Therapeutics Market, Top Seven Markets, Treatment Usage Pattern (‘000), 2011-2018 27
Table 12: Liver Cancer Therapeutics Market, US, Revenue ($m), 2004-2011 30
Table 13: Liver Cancer Therapeutics Market, US, Revenue Forecasts ($m), 2011-2018 31
Table 14: Liver Cancer Therapeutics Market, US, Annual Cost of Therapy ($), 2004-2011 32
Table 15: Liver Cancer Therapeutics Market, US, Annual Cost of Therapy ($), 2011-2018 32
Table 16: Liver Cancer Therapeutics Market, US, Treatment Usage Pattern (‘000), 2004-2011 33
Table 17: Liver Cancer Therapeutics Market, US, Treatment Usage Pattern (‘000), 2011-2018 33
Table 18: Liver Cancer Therapeutics Market, Top Five European Countries, Revenue ($m), 2004-2011 35
Table 19: Liver Cancer Therapeutics Market, Top Five European Countries, Revenue Forecast ($m), 2011-2018 35
Table 20: Liver Cancer Therapeutics Market to 2018, Top Five European Countries, Annual Cost of Therapy ($), 2004-2011 36
Table 21: Liver Cancer Therapeutics Market to 2018, Top Five European Countries, Annual Cost of Therapy ($), 2011-2018 36
Table 22: Liver Cancer Therapeutics Market, Top Five European Countries, Treatment Usage Pattern (‘000), 2004-2011 37
Table 23: Liver Cancer Therapeutics Market, Top Five European Countries, Treatment Usage Pattern (‘000), 2011-2018 37
Table 24: Liver Cancer Therapeutics Market, Japan, Revenue ($m), 2004-2011 38
Table 25: Liver Cancer Therapeutics Market, Japan, Revenue Forecast ($m), 2011-2018 39
Table 26: Liver Cancer Therapeutics Market, Japan, Annual Cost of Therapy ($), 2004-2011 39
Table 27: Liver Cancer Therapeutics Market, Japan, Annual Cost of Therapy ($), 2011-2018 39
Table 28: Liver Cancer Therapeutics Market, Japan, Treatment Usage Pattern (‘000), 2004-2011 40
Table 29: Liver Cancer Therapeutics Market, Japan, Treatment Usage Pattern (‘000), 2011-2018 40
Table 30: Liver Cancer Therapeutics Market, Global, Pipeline Products, by Stage of Development, 2012 42
Table 31: Liver Cancer Therapeutics Market, Global, Phase III Pipeline 43
Table 32: Liver Cancer Therapeutics Market, Global, Phase II/III Pipeline 44
Table 33: Liver Cancer Therapeutics Market, Global, Phase II Pipeline 44
Table 34: Liver Cancer Therapeutics Market, Global, Phase I/II Pipeline 45
Table 35: Liver Cancer Therapeutics Market, Global, Phase I Pipeline 46
Table 36: Liver Cancer Therapeutics Market, Global, Preclinical, 2012 47
Table 37: Liver Cancer Therapeutics Market, Global, Discovery, 2012 47
Table 38: Liver Cancer Therapeutics Market, Global, Bayer AG, Pharmaceutical Brands, 2012 51
Table 39: Liver Cancer Therapeutics Market, Global, Dainippon Sumitomo Pharma, Pharmaceutical Brands, 2012 52
Table 40: Liver Cancer Therapeutics Market, Global, Deals by Type of Agreement, 2007-2012 53
Table 41: Liver Cancer Therapeutics Market, Global, Deals by Geography, 2007-2012 54
Table 42: Liver Cancer Therapeutics Market, Global, Deals by Year, 2007-2012 55
Table 43: Liver Cancer Therapeutics Market, Global, Major M&A Deals, 2007-2012 56
Table 44: Liver Cancer Therapeutics Market, Global, Major Licensing Agreement Deals, 2007-2012 58
Table 45: Liver Cancer Therapeutics Market, Global, Major Co-Development Deals, 2007-2012 62

List of Figures


Figure 1: Liver Cancer Therapeutics Market, Global, Hepatocellular Carcinoma, Treatment Options, 2012 12
Figure 2: Liver Cancer Therapeutics Market, Global, Hepatocellular Carcinoma, General Treatment Algorithm 15
Figure 3: Liver Cancer Therapeutics Market, Global, Hepatocellular Carcinoma, Stage I and II, Treatment Algorithm 16
Figure 4: Liver Cancer Therapeutics Market, Global, Hepatocellular Carcinoma, Stage III and IV, Treatment Algorithm 17
Figure 5: Liver Cancer Therapeutics Market, Top Seven Markets, Revenue Forecasts ($m), 2004-2018 19
Figure 6: Liver Cancer Therapeutics Market, Top Seven Markets, Revenue Forecasts by Geography ($m), 2004-2018 20
Figure 7: Liver Cancer Therapeutics Market, Top Seven Markets, Annual Cost of Therapy ($), 2004-2018 22
Figure 8: Liver Cancer Therapeutics Market, Top Seven Markets, Treatment Usage Pattern (‘000), 2004-2018 27
Figure 9: Liver Cancer Therapeutics Market, Top Seven Markets, Drivers and Barriers, 2012 29
Figure 10: Liver Cancer Therapeutics Market, US, Revenue Forecasts ($m), 2004-2018 30
Figure 11: Liver Cancer Therapeutics Market, US, Annual Cost of Therapy ($), 2004-2018 32
Figure 12: Liver Cancer Therapeutics Market, US, Treatment Usage Pattern (‘000), 2004-2018 33
Figure 13: Liver Cancer Therapeutics Market, Top Five European Countries, Revenue Forecast ($m), 2004-2018 34
Figure 14: Liver Cancer Therapeutics Market, Top Five European Countries, Market Revenue ($m), 2004-2018 35
Figure 15: Liver Cancer Therapeutics Market, Top Five European Countries, Annual Cost of Therapy ($), 2004-2018 36
Figure 16: Liver Cancer Therapeutics Market, Top Five European Countries, Treatment Usage Pattern (‘000), 2004-2018 37
Figure 17: Liver Cancer Therapeutics Market, Japan, Revenue Forecast ($m), 2004-2018 38
Figure 18: Liver Cancer Therapeutics Market, Japan, Annual Cost of Therapy ($), 2004-2018 39
Figure 19: Liver Cancer Therapeutics Market, Japan, Treatment Usage Pattern (‘000), 2004-2018 40
Figure 20: Liver Cancer Therapeutics Market, Global, Pipeline Products, by Stage of Development, 2012 41
Figure 21: Liver Cancer Therapeutics Market, Global, Deals by Type of Agreement, 2007-2012 53
Figure 22: Liver Cancer Therapeutics Market, Global, Deals by Geography, 2007-2012 54
Figure 23: Liver Cancer Therapeutics Market, Global, Deals by Year, 2007-2012 55
Figure 24: GBI Research Market Forecasting Model 71

Upcoming Reports:

Image Guided Surgery Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020
By - Transparency Market Research
Image guided surgery makes use of preoperative images to precisely guide surgical instruments by correlating the operative field. The image guidance systems also help in seamless procedure planning, thus reducing chances of error and also minimizing procedure time. With image guided systems, overall productivity is increased and being minimally invasive, allows quick recovery and shorter hospital stay. The technique was initially developed for neurosurgeries, which is one of the most critical procedures. ENT surgeries still remain the main area of application of image guided...
Physician Office Laboratory (POL) Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Physician office lab (POL) term is wide and diverse, it encompasses physician’s practices as small (2 to 5 doctors) to large practitioners (200 physicians) that operate labs similar to small laboratory hospitals. Hospitals and commercial labs perform tests, but physicians prefer to perform in-house testing in order to enhance the patient care. In-house testing facilitates physicians to no longer rely on the reference labs for test results. In addition, physicians can obtain faster results from their own labs and increase profits. POL also reduces the chances of loss or...
Measurement While Drilling Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth And Forecast 2014 - 2020
By - Transparency Market Research
Measurement while drilling market is growing with the increasing drilling activities across the world. Huge investment in exploration and production activities by oil companies will prove to be a boom for the measurement while drilling market during the forecast period. Measurement while drilling is a type of well logging services. In this, a measurement tool is incorporated in drilling string to access the real time information. This information helps the operator to steer the drilling process. The real time information is very important for a drilling operation to avoid deviation from...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

A Health Tech Incubator Started by GE Healthcare
Oct 30, 2014  
For the very first time, a health tech start up campus has been established by GE Healthcare at its headquarters at Helsinki, Finland. This area already has about twenty such healthcare start ups that are working on cloud services, wireless technologies, apps, and sensors that aim at improving healthcare. The main rationale behind such a step is providing opportunities for further...
Net Earnings of DuPont Increases 52% despite Agricultural Turmoil
Oct 29, 2014  
DuPont - The Wilmington, Del-based leading chemical company faced decline of three percent sales to $7.5 billion in the quarter ending of September 30. The company’s third-quarter earnings were increased by 52 percent to $433 million albeit the slow global growth and agricultural downside.   The company witnessed the biggest drags from chemical sales with eight percent...
Appeal for Sanitization in Construction Industry through Government Regulations: CIOB Ghana
Oct 29, 2014  
Rockson Dogbegah - The Chairman of the Chartered Institute of Building Ghana commented that the construction industry needs a thorough cleaning up and assurance of proper growth. Mr. Dogbegah also said that a few factors are extremely important for a proper development in the construction industry. These include keen adherence to standards, supreme sense of professionalism, and sheer pursuance...
Facebook Hints of Rise in Expenses in 2015, Shares Drop
Oct 29, 2014  
Facebook has announced on Tuesday that it is prepping for a dramatic rise in spending in the year 2015. This warning has come combined with a projected slowdown in the company’s revenues after revenues were analyzed at the end of the third quarter of the year. The plans of such hefty spending in the next financial year by the company are indicative of stress in the investor...
Samsung Records Poorest Profits in Q3 2014
Oct 29, 2014  
In the quarter ending September 2014, Samsung Electronics Co. Ltd registered the smallest earnings ever in two years. The drop in earnings can be easily attributed to heavy competition from new Chinese devices and the Apple phones. The net income stood at US$4 billion for the South Korea-based company. Apple has been Samsung’s strongest contender ever since the latter entered the...